SyntekaBio, Inc. (KOSDAQ:226330)
South Korea
· Delayed Price · Currency is KRW
2,905.00
-200.00 (-6.44%)
At close: Mar 9, 2026
SyntekaBio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 70,471 | 80,107 | 216,882 | 115,982 | 241,650 | 307,326 |
| Market Cap Growth | -47.34% | -63.06% | 87.00% | -52.00% | -21.37% | - |
| Enterprise Value | 81,234 | 71,044 | 189,591 | 86,513 | - | - |
| Last Close Price | 2905.00 | 4388.79 | 11904.07 | 7172.54 | 14963.68 | 19227.08 |
| PS Ratio | 39.52 | 662.66 | 1757.47 | 475.35 | 763.13 | 504.08 |
| PB Ratio | 5.92 | 3.21 | 6.95 | 3.69 | 8.75 | 7.40 |
| P/TBV Ratio | 6.13 | 3.27 | 7.05 | 3.76 | 8.89 | 7.48 |
| EV/Sales Ratio | 45.55 | 587.69 | 1536.32 | 354.57 | - | - |
| Debt / Equity Ratio | 1.06 | 0.29 | 0.07 | 0.35 | 0.32 | 0.03 |
| Net Debt / Equity Ratio | 0.91 | -0.19 | -0.56 | -0.77 | -1.59 | -0.96 |
| Net Debt / EBITDA Ratio | -1.10 | 0.40 | 1.67 | 2.35 | 5.67 | 6.63 |
| Net Debt / FCF Ratio | -0.99 | 0.29 | 1.01 | 1.43 | 3.25 | 7.34 |
| Asset Turnover | 0.04 | 0.00 | 0.00 | 0.00 | 0.01 | - |
| Quick Ratio | 0.12 | 0.74 | 1.02 | 1.59 | 28.00 | 39.87 |
| Current Ratio | 0.20 | 0.77 | 1.13 | 1.69 | 30.82 | 40.04 |
| Return on Equity (ROE) | -86.04% | -25.68% | -36.36% | -15.25% | -42.80% | - |
| Return on Assets (ROA) | -17.98% | -18.46% | -14.13% | -11.93% | -9.87% | - |
| Return on Capital Employed (ROCE) | -82.50% | -52.10% | -36.60% | -35.30% | -13.50% | -16.20% |
| Earnings Yield | -25.02% | -9.00% | -5.25% | -3.89% | -6.13% | -2.11% |
| FCF Yield | -15.39% | -20.24% | -8.04% | -14.57% | -5.59% | -1.78% |
| Buyback Yield / Dilution | -0.06% | -24.72% | -5.94% | -0.37% | -1.65% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.